🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

✅ Classification of cutaneous #lupus in 2024 ⬇️ #dermatology

#VEXAS can present as atypical &/or refractory #ANCA-associated #vasculitis Consider possibility of VEXAS in cases of AAV ▶️Refractory to multiple treatment ▶️Atypical kidney biopsy 👉🏽academic.oup.com/rheumap/articl… via Rheumatology & Rheumatology Advances in Practice

👋 HANDS in systemic disorders ( excluding nail signs and dynamic signs) An infographic

Syndrome VEXAS - Par Paul Breillat (interne en Médecine Interne, Paris, France) #VEXAS #InternistAcademy 2024

Myths by Daniel Clauw Small fiber neuropathy - misnomer, non-specific, not worth getting a skin biopsy Fibromyalgia is not autoimmune - it is nociplastic pain and treated differently #ACR24 Review Course Dr. John Cush

#ACR24 Year in Review: 💡GLP1i significantly decreased knee OA pain over time (or was it the wt loss itself?🤨) 💡CD19 CAR T-Cell therapy has potential to treat/cure many autoimmune diseases (are risks and $ worth the benefit?) 💡 High risk of CV events within 30 days of gout

✅ Current pipeline of investigational agents / drug development in #Lupus, updated with #ACR2024 data ⬇️ What would you add? Which ones are the most promising? There is truly hope for patients with #SLE. Please do let me know if I have forgotten something & I will reupdate.

Meet the #LUPUS2025 Organizing Committee: → Zahi Touma – Chair → Dafna Gladman – Co-Chair, Scientific Chair → Joan Wither – Co-Chair, Scientific Vice-Chair → Ali Duarte-Garcia – Co-Chair Join us in Toronto! 🔗 bit.ly/3Oi5DYQ #Lupus #SLE #Rheumatology #Rheum

Cryoglobulinemic Vasculitis Types II/III doi.org/10.1097/BOR.00… #RheumTwitter #Rheumatology #MedX Dr. Akhil 🇮🇳 Dr Ihab Suliman Janet Pope

Congratulations to our new fellows! We are so excited! Brown University RWMC Internal Medicine Residency

NEW REVIEW—Yujie Shen and colleagues discuss personalised precision treatment for Still's disease based on molecular characteristics and disease progression thelancet.com/journals/lanrh…

Love SCIP mornings with this power team 💪

🆕 Visual Abstract w/ Healio Rheumatology 🟢 🔥 New Therapy for IgG4-Related Disease: 📷 RCT of inebilizumab (anti-CD19) vs Placebo in IgG4-RD 👥 Adults with IgG4-RD involving ≥ 2 organs 📷 Results: ⇣ in flare rate + ⇡ complete remission 📷: tinyurl.com/IgG4RDHealio #IgG4RD #RheumX

🎉 Congratulations to UHN’s Dr. Dafna Gladman on being appointed to the Order of Canada! 🇨🇦 Her foundational work in psoriatic #arthritis and #lupus has transformed patient care and inspired researchers worldwide. Read more ➡️ uhnresearch.ca/news/appointed… #OrderOfCanada #TeamUHN

NEW RESEARCH—In patients with #gout initiating urate-lowering therapy, the risk of cardiovascular events was reduced in those prescribed #colchicine prophylaxis compared with no prophylaxis thelancet.com/journals/lanrh…

Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (#SAPHO) syndrome a classic term in #rheumatology that should no longer be used, at least according to the expert consensus recommendations for the diagnosis and treatment of chronic non-­bacterial #osteitis (CNO) in adults.

#JanuaryIssue | EULAR and PReS now view systemic juvenile idiopathic arthritis and adult-onset Still’s disease as a single disease — Still’s disease. Qiongyi Hu & Chengde Yang discuss this new consensus and the implications for Still’s disease bit.ly/3ZItp5G

Best team right here

Thank you MGH Rheumatology for delivering such an insightful and informative course! Brown Rheumatology

Brown, Metrohealth, and MedStar Rheum fellows take over Chicago for #SOTA25 American College of Rheumatology Brown Rheumatology